Skip to main content
Clinical Trials/NCT00867971
NCT00867971
Unknown
Not Applicable

Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?

Assaf-Harofeh Medical Center1 site in 1 country100 target enrollmentFebruary 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Growth Hormone Treatment
Sponsor
Assaf-Harofeh Medical Center
Enrollment
100
Locations
1
Primary Endpoint
Intraoccular pressure in children treated with RGH
Last Updated
17 years ago

Overview

Brief Summary

Recombinant growth hormone is a common therapy in the pediatric population. A number of associated side effects have been described. Several years ago, a case report was published concerning a child that was treated with RGH and developed acute glaucoma. To date no study has evaluated the connection.

Registry
clinicaltrials.gov
Start Date
February 2009
End Date
October 2010
Last Updated
17 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age 6-18 years
  • treatment with recombinant growth hormone

Exclusion Criteria

  • Underlying Chronic diseases
  • Family history of eye diseases
  • elevated occular pressure prior to starting treatment

Outcomes

Primary Outcomes

Intraoccular pressure in children treated with RGH

Time Frame: 2 years

Study Sites (1)

Loading locations...

Similar Trials